PIPA528812
Hepatitis B Small S Protein Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA528812-Each-of-1 | In Stock | ₹ 49,261.50 |
PIPA528812 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 49,261.50
GST (18%): ₹ 8,867.07
Total Price: ₹ 58,128.57
Antigen
Hepatitis B Small S Protein
Classification
Polyclonal
Conjugate
Unconjugated
Gene Alias
HBV; HBV1a; HBV1a small S; HepB; small S Protein
Immunogen
Synthetic peptide corresponding to a region within amino acids 150 and 212 of small S Protein (HBV1a)
Quantity
100 μL
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
Western Blot
Concentration
0.64 mg/mL
Formulation
0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Recommended positive controls: medium of 293T transfect HBV1a_small S (4 days)
- Store product as a concentrated solution
- Centrifuge briefly prior to opening the vial
- The hepatitis B virus is an important cause of acute and chronic liver disease
- It is also the most common form of parenterally transmitted viral hepatitis
- The HBV surface protein antigens (HBsAg) are comprised of three carboxyl co terminal HBs proteins termed large (LHBs), middle (MHBs) and small (SHBs, also called major) protein
- LHBs and MHBs also share the highly hydrophobic, repetitive, membrane spanning S domain
- In addition, MHBs has a 55 amino acid region called preS2
- The virus is estimated to affect some 350 million people worldwide
- Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries
- Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus
- In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas
- There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.